IBER Salvage Treatment Followed by Ibrutinib Maintenance for Relapsed or Refractory PCNSL
Condition: Primary Central Nervous System Lymphoma Intervention: Drug: IBER salvage chemotherapy followed by ibrutinib maintenance therapy Sponsor: Deok-Hwan Yang Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials